OVID

Ovid TherapeuticsB

Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences

At close

2026-07-20

Current thesis

The constructive case is that Ovid now has two live clinical value drivers: OV329 has generated supportive dose-escalation safety/PK data for patient studies, and OV4071 has entered Phase 1, while the larger cash balance extends operating flexibility [#SEC-8K-2026-03-18] [#PR-EARNINGS-2026-05-12].

Posture

Constructive

Lead driver

Momentum

What changed

Momentum remains the lead driver in the composite.

What can break

Clinical readouts for OV329 and OV4071 remain the core value drivers, so any weak safety, PK, exposure, or proof-of-concept signal could materially pressure the stock.

Momentum

Value

Sentiment

Setup hits (3d)

0 · Net Neutral

AI TargetsBase $2.40 · Bull $3.60 · Bear $1.40

Data freshness

Prices

As of 2026-07-20

Fundamentals

As of 2026-07-20 • Vendor: Data Vendor v1

Scores

As of 2026-07-20 • Model: HYBRID_IC_RP

AI Memo

As of 2026-06-20 • Model: RankAlpha Sentiment Codex

Investment thesis

As of 2026-07-20

Supporting evidence

What

Grade B · Constructive

Confidence Medium · Net Neutral

Target $5.50

Why

Momentum93 · Δ7d -

Value41 · Δ7d +0.0

Sentiment51 · Δ7d -

So what

Strength-led posture (Net Neutral). Favor watchlist adds and disciplined entries.

Lead driver: Momentum · See technicals

Momentum

26% active weight

Current posture

7d trendTrend unavailable

Trend unavailable

Δ7d

Δ21d

Value

39% active weight

Current posture

7d trendFlat

Δ7d

+0.0

Δ21d

-0.1

Sentiment

34% active weight

Current posture

7d trendTrend unavailable

Trend unavailable

Δ7d

Δ21d

Why this grade

Composite grade B. Momentum 92.8 / Value 41.1 / Sentiment 50.6

Fundamentals (TTM)

As of 2026-07-20

Market Cap

$430.21M

Beta

0.26

Shares Out

186.64M

P/E (TTM) · Derived

-9.8

P/S (TTM)

32.69

P/FCF (TTM) · Derived

-4.83

Rev YoY

-100.0%

EPS YoY

-13.4%

Gross Margin

+97.3%

Op Margin

-618.3%

Net Debt

-$56.22M

Current Ratio

10.17

As of 2026-07-20 • Updated nightlySource: Internal modelMethodology